Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Glycinebetaine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 1/20 | 0.39 |
| ▸ | RAD52 | P43351 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | CPT2 | P23786 | 2/20 | 0.35 |
| ▸ | CPT1A | P50416 | 2/20 | 0.35 |
| ▸ | CPT1B | Q92523 | 2/20 | 0.35 |
| ▸ | FABP3 | P05413 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycinebetaine SCHEMBL18837047 | 0.86 | PLA2G2A (0.39) | PLA2G2ARAD52NPSR1CPT2CPT1A | |
| Glycinebetaine SCHEMBL18837046 | 0.86 | PLA2G2A (0.39) | PLA2G2ARAD52NPSR1CPT2CPT1A | |
| Glycinebetaine SCHEMBL18837045 | 0.86 | PLA2G2A (0.39) | PLA2G2ARAD52NPSR1CPT2CPT1A | |
| Glycinebetaine SCHEMBL18837059 | 0.86 | PLA2G2A (0.39) | PLA2G2ARAD52NPSR1CPT2CPT1A | |
| Glycinebetaine SCHEMBL6546572 | 0.86 | PLA2G2A (0.39) | PLA2G2ARAD52NPSR1CPT2CPT1A | |
| Glycinebetaine SCHEMBL18837052 | 0.86 | PLA2G2A (0.39) | PLA2G2ARAD52NPSR1CPT2CPT1A | |
| SCHEMBL7497643 | 0.84 | PLA2G2A (0.46) | PLA2G2AFABP3 | |
| SCHEMBL2175912 | 0.84 | PLA2G2A (0.46) | PLA2G2AFABP3 | |
| SCHEMBL7500721 | 0.84 | PLA2G2A (0.46) | PLA2G2AFABP3 | |
| SCHEMBL5495142 | 0.84 | PLA2G2A (0.46) | PLA2G2AFABP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4225035-A1 | ANTIMICROBIAL FACEMASK | BMG (British Medical Group) Limited (GB) | 2023-08-16 | — | — | EP | claimed |
| CN-114829677-A | Electroplating composition and method for depositing chromium coating on substrate | 德国艾托特克有限两合公司 | 2022-07-29 | — | — | CN | claimed |
| CN-114829303-A | Process for recovering organic salts from industrial process streams | 塞特工业公司 | 2022-07-29 | — | — | CN | claimed |
| EP-3826719-A1 | SYSTEMS AND METHODS FOR PRODUCING GENE THERAPY FORMULATIONS | Voyager Therapeutics, Inc. (US) | 2021-06-02 | — | — | EP | claimed |
| CN-112770812-A | System and method for producing gene therapy formulations | 沃雅戈治疗公司 | 2021-05-07 | — | — | CN | claimed |
| WO-2021022286-A1 | ANTIMICROBIAL COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2021-02-04 | — | — | WO | claimed |
| CN-111819289-A | Self-assembling diagnostic array platform | 酷商瑞士股份公司 | 2020-10-23 | — | — | CN | claimed |
| WO-2020023612-A1 | SYSTEMS AND METHODS FOR PRODUCING GENE THERAPY FORMULATIONS | VOYAGER THERAPEUTICS, INC. (US) | 2020-01-30 | — | — | WO | claimed |
| EP-2512614-A1 | METHODS AND COMPOSITIONS FOR THE REMOVAL OF IMPURITIES FROM AN IMPURITY-LOADED IONIC LIQUID | Cytec Technology Corp. (US) | 2012-10-24 | — | — | EP | claimed |
| WO-2011081764-A1 | METHODS AND COMPOSITIONS FOR THE REMOVAL OF IMPURITIES FROM AN IMPURITY-LOADED IONIC LIQUID | CYTEC TECHNOLOGY CORP. (US) | 2011-07-07 | — | — | WO | claimed |
| CN-116249811-A | Dispersion of polyester particles | 科思创(荷兰)有限公司 | 2023-06-09 | — | — | CN | disclosed |
| CN-116234849-A | Method for preparing a recyclable textile product and said product | 科思创(荷兰)有限公司 | 2023-06-06 | — | — | CN | disclosed |
| CN-112481360-B | DNA hands-free direct amplification reagent for various case sample forensic science DNA typing detection | 中国合格评定国家认可中心 | 2023-01-03 | — | — | CN | disclosed |
| EP-4097239-A2 | METHODS AND SYSTEMS FOR PRODUCING AAV PARTICLES | Voyager Therapeutics, Inc. (US) | 2022-12-07 | — | — | EP | disclosed |
| EP-4073000-A1 | METHODS FOR RECOVERING ORGANIC SALTS FROM INDUSTRIAL PROCESS STREAMS | Cytec Industries, Inc. (US) | 2022-10-19 | — | — | EP | disclosed |
| EP-2496947-A1 | POSITIVELY CHARGED SPECIES AS BINDING REAGENTS IN THE SEPARATION OF PROTEIN AGGREGATES FROM MONOMERS | Novartis AG (CH) | 2012-09-12 | — | — | EP | disclosed |
| WO-2011057029-A1 | POSITIVELY CHARGED SPECIES AS BINDING REAGENTS IN THE SEPARATION OF PROTEIN AGGREGATES FROM MONOMERS | NOVARTIS AG (CH) | 2011-05-12 | — | — | WO | disclosed |
| US-20110065834-A1 | ENCAPSULATED PIGMENT PARTICLES | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2011-03-17 | — | — | US | disclosed |
| EP-2240409-A1 | METHODS AND COMPOSITIONS FOR THE REMOVAL OF IMPURITIES AND WATER FROM THE BAYER PROCESS | CYTEC TECHNOLOGY CORP. (US) | 2010-10-20 | — | — | EP | disclosed |
| WO-2009086273-A1 | METHODS AND COMPOSITIONS FOR THE REMOVAL OF IMPURITIES AND WATER FROM THE BAYER PROCESS | CYTEC TECHNOLOGY CORP. (US) | 2009-07-09 | — | — | WO | disclosed |